APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Haemophilus Influenzae Type B Vaccine Industry Growth and Trends Forecast to 2032

Report ID 173996700122 December 202598 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilus Influenzae Type B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Haemophilus Influenzae Type B Vaccine include Takeda Pharmaceuticals Company, Sanofi, Novartis, Merck, Lanzhou Institute of Biologica, GlaxoSmithKline, Walvax Biotechnology and Immunize BC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Haemophilus Influenzae Type B Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Haemophilus Influenzae Type B Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Haemophilus Influenzae Type B Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Haemophilus Influenzae Type B Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Haemophilus Influenzae Type B Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Haemophilus Influenzae Type B Vaccine Market by Company

Takeda Pharmaceuticals Company

Sanofi

Novartis

Merck

Lanzhou Institute of Biologica

GlaxoSmithKline

Walvax Biotechnology

Immunize BC

Haemophilus Influenzae Type B Vaccine Segment by Type

Liquid Combination HIB

Liquid Monovalent HIB

Lyophilized Combination HIB

Lyophilized Monovalent HIB

Haemophilus Influenzae Type B Vaccine Segment by Application

Pharmaceutical and Biotechnology Companies

Hospital

Research Institutions

Academic Institutions

Other

Haemophilus Influenzae Type B Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Haemophilus Influenzae Type B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liquid Combination HIB Table 2. Major Company of Liquid Monovalent HIB Table 3. Major Company of Lyophilized Combination HIB Table 4. Major Company of Lyophilized Monovalent HIB Table 5. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 7. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Haemophilus Influenzae Type B Vaccine Price by Type (2021-2026) & (US$/unit) Table 11. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 12. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Haemophilus Influenzae Type B Vaccine Price by Type (2027-2032) & (US$/unit) Table 16. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 17. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 19. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 23. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Haemophilus Influenzae Type B Vaccine Industry Trends Table 27. Haemophilus Influenzae Type B Vaccine Industry Drivers Table 28. Haemophilus Influenzae Type B Vaccine Industry Opportunities and Challenges Table 29. Haemophilus Influenzae Type B Vaccine Industry Restraints Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Haemophilus Influenzae Type B Vaccine Sales by Company (2021-2026) & (k units) Table 33. Global Haemophilus Influenzae Type B Vaccine Sales Share by Company (2021-2026) Table 34. Global Haemophilus Influenzae Type B Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Haemophilus Influenzae Type B Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Haemophilus Influenzae Type B Vaccine Major Company Production Sites and Headquarters Table 37. Global Haemophilus Influenzae Type B Vaccine Company, Product Type & Application Table 38. Global Haemophilus Influenzae Type B Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Haemophilus Influenzae Type B Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Haemophilus Influenzae Type B Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2027-2032) & (k units) Table 48. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Haemophilus Influenzae Type B Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 54. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Haemophilus Influenzae Type B Vaccine Price by Application (2021-2026) & (US$/unit) Table 58. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 59. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Haemophilus Influenzae Type B Vaccine Price by Application (2027-2032) & (US$/unit) Table 63. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 64. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 66. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 70. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Pharmaceuticals Company Company Information Table 74. Takeda Pharmaceuticals Company Business Overview Table 75. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio Table 77. Takeda Pharmaceuticals Company Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio Table 82. Sanofi Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio Table 87. Novartis Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Merck Haemophilus Influenzae Type B Vaccine Product Portfolio Table 92. Merck Recent Development Table 93. Lanzhou Institute of Biologica Company Information Table 94. Lanzhou Institute of Biologica Business Overview Table 95. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio Table 97. Lanzhou Institute of Biologica Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Walvax Biotechnology Company Information Table 104. Walvax Biotechnology Business Overview Table 105. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio Table 107. Walvax Biotechnology Recent Development Table 108. Immunize BC Company Information Table 109. Immunize BC Business Overview Table 110. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio Table 112. Immunize BC Recent Development Table 113. North America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 115. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2026) Table 116. North America Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 117. North America Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 118. North America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Haemophilus Influenzae Type B Vaccine Market Share by Country (2021-2026) Table 121. North America Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Haemophilus Influenzae Type B Vaccine Market Share Forecast by Country (2027-2032) Table 123. Europe Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 125. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2026) Table 126. Europe Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 127. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Haemophilus Influenzae Type B Vaccine Market Share by Country (2021-2026) Table 131. Europe Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Haemophilus Influenzae Type B Vaccine Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 135. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 137. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Share by Country (2021-2026) Table 141. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Share Forecast by Country (2027-2032) Table 143. Latin America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 145. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2026) Table 146. Latin America Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 147. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Haemophilus Influenzae Type B Vaccine Market Share by Country (2021-2026) Table 151. Latin America Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Haemophilus Influenzae Type B Vaccine Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 155. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 157. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share by Country (2021-2026) Table 161. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Haemophilus Influenzae Type B Vaccine Distributors List Table 166. Haemophilus Influenzae Type B Vaccine Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Vaccine Image Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Haemophilus Influenzae Type B Vaccine Sales (2021-2032) & (k units) Figure 5. Liquid Combination HIB Image Figure 6. Global Liquid Combination HIB Sales YoY Growth (2021-2032) & (k units) Figure 7. Liquid Monovalent HIB Image Figure 8. Global Liquid Monovalent HIB Sales YoY Growth (2021-2032) & (k units) Figure 9. Lyophilized Combination HIB Image Figure 10. Global Lyophilized Combination HIB Sales YoY Growth (2021-2032) & (k units) Figure 11. Lyophilized Monovalent HIB Image Figure 12. Global Lyophilized Monovalent HIB Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Haemophilus Influenzae Type B Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Haemophilus Influenzae Type B Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pharmaceutical and Biotechnology Companies Image Figure 28. Global Pharmaceutical and Biotechnology Companies Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 31. Research Institutions Image Figure 32. Global Research Institutions Sales YoY Growth (2021-2032) & (k units) Figure 33. Academic Institutions Image Figure 34. Global Academic Institutions Sales YoY Growth (2021-2032) & (k units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Haemophilus Influenzae Type B Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Haemophilus Influenzae Type B Vaccine Market Share by Application 2025 VS 2032 Figure 39. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. North America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application in 2025 Figure 49. North America Haemophilus Influenzae Type B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Haemophilus Influenzae Type B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Haemophilus Influenzae Type B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Haemophilus Influenzae Type B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Haemophilus Influenzae Type B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Haemophilus Influenzae Type B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Haemophilus Influenzae Type B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Haemophilus Influenzae Type B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Haemophilus Influenzae Type B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Haemophilus Influenzae Type B Vaccine Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Haemophilus Influenzae Type B Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Combination HIB
  • Liquid Monovalent HIB
  • Lyophilized Combination HIB
  • Lyophilized Monovalent HIB
Applications
  • Pharmaceutical and Biotechnology Companies
  • Hospital
  • Research Institutions
  • Academic Institutions
  • Other
Companies covered
  • Takeda Pharmaceuticals Company
  • Sanofi
  • Novartis
  • Merck
  • Lanzhou Institute of Biologica
  • GlaxoSmithKline
  • Walvax Biotechnology
  • Immunize BC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Haemophilus Influenzae Type B Vaccine Market by Type
  6. 1.3.1 Liquid Combination HIB
  7. 1.3.2 Liquid Monovalent HIB
  8. 1.3.3 Lyophilized Combination HIB
  9. 1.3.4 Lyophilized Monovalent HIB
  10. 1.4 Global Haemophilus Influenzae Type B Vaccine Market Size by Type
  11. 1.4.1 Global Haemophilus Influenzae Type B Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Haemophilus Influenzae Type B Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Haemophilus Influenzae Type B Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Haemophilus Influenzae Type B Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Haemophilus Influenzae Type B Vaccine Price (2021-2026)
  4. 3.4 Global Haemophilus Influenzae Type B Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Haemophilus Influenzae Type B Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Haemophilus Influenzae Type B Vaccine Company, Product Type & Application
  7. 3.7 Global Haemophilus Influenzae Type B Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Haemophilus Influenzae Type B Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Haemophilus Influenzae Type B Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Haemophilus Influenzae Type B Vaccine Tier 1, Tier 2, and Tier 3
4 Haemophilus Influenzae Type B Vaccine Regional Status and Outlook
  1. 4.1 Global Haemophilus Influenzae Type B Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Haemophilus Influenzae Type B Vaccine Historic Market Size by Region
  3. 4.2.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Haemophilus Influenzae Type B Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Haemophilus Influenzae Type B Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Haemophilus Influenzae Type B Vaccine by Application
  1. 5.1 Haemophilus Influenzae Type B Vaccine Market by Application
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research Institutions
  5. 5.1.4 Academic Institutions
  6. 5.1.5 Other
  7. 5.2 Global Haemophilus Influenzae Type B Vaccine Market Size by Application
  8. 5.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Haemophilus Influenzae Type B Vaccine Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Haemophilus Influenzae Type B Vaccine Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceuticals Company
  2. 6.1.1 Takeda Pharmaceuticals Company Company Information
  3. 6.1.2 Takeda Pharmaceuticals Company Business Overview
  4. 6.1.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio
  6. 6.1.5 Takeda Pharmaceuticals Company Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Haemophilus Influenzae Type B Vaccine Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Lanzhou Institute of Biologica
  26. 6.5.1 Lanzhou Institute of Biologica Company Information
  27. 6.5.2 Lanzhou Institute of Biologica Business Overview
  28. 6.5.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio
  30. 6.5.5 Lanzhou Institute of Biologica Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Walvax Biotechnology
  38. 6.7.1 Walvax Biotechnology Company Information
  39. 6.7.2 Walvax Biotechnology Business Overview
  40. 6.7.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio
  42. 6.7.5 Walvax Biotechnology Recent Developments
  43. 6.8 Immunize BC
  44. 6.8.1 Immunize BC Company Information
  45. 6.8.2 Immunize BC Business Overview
  46. 6.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio
  48. 6.8.5 Immunize BC Recent Developments
7 North America by Country
  1. 7.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country
  2. 7.1.1 North America Haemophilus Influenzae Type B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Haemophilus Influenzae Type B Vaccine Market Size by Country
  6. 7.2.1 North America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country
  2. 8.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country
  6. 8.2.1 Europe Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Haemophilus Influenzae Type B Vaccine Sales by Country
  2. 10.1.1 South America Haemophilus Influenzae Type B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Haemophilus Influenzae Type B Vaccine Market Size by Country
  6. 10.2.1 South America Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Haemophilus Influenzae Type B Vaccine Value Chain Analysis
  2. 12.1.1 Haemophilus Influenzae Type B Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Haemophilus Influenzae Type B Vaccine Production Mode & Process
  7. 12.2 Haemophilus Influenzae Type B Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Haemophilus Influenzae Type B Vaccine Distributors
  10. 12.2.3 Haemophilus Influenzae Type B Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst